OrthoPediatrics EBIT per Employee
The EBIT per Employee of OrthoPediatrics (KIDS) as of Aug 17, 2026 is -353,106.38 USD. In the previous year, EBIT per Employee was -418,170.21 USD — a change of -15.56% (higher).
Get this data via API
Financial Data API
EBIT per Employee
-353,106.38USD
YoY
-15.56%
Last updated:
EBIT per Employee of OrthoPediatrics is 2026 -353,106.38 USD. EBIT per Employee of OrthoPediatrics was 2025 -418,170.21 USD. It decreases by -15.56% higher compared to the previous year.
Access this data via the Eulerpool API
OrthoPediatrics Stock analysis
What does OrthoPediatrics do? OrthoPediatrics Corp is an American company specializing in products and solutions for orthopedic disorders in children and adolescents. The company was founded in 2006 and is headquartered in Warsaw, Indiana.
Business model:
The business model of OrthoPediatrics Corp focuses on the development and marketing of implants and surgical instruments for the treatment of orthopedic disorders in children and adolescents. The company works closely with specialists and hospitals to develop innovative and specialized products that meet the needs of children and adolescents.
The company specializes in three areas:
1. Trauma and deformity correction – treatment of spinal and limb injuries as well as congenital deformity disorders in children and adolescents.
2. Scoliosis and spinal surgery – correction of spinal deformity and treatment of scoliosis and kyphosis in children and adolescents.
3. Sports medicine and orthobiology – development of solutions to support bone healing and regeneration in children and adolescents after an injury or surgery.
Products:
OrthoPediatrics Corp offers a variety of products tailored to the specific needs and requirements of children and adolescents. These include:
- Bands and implants for repairing broken bones and joint injuries.
- Surgical instruments and implants for correcting spinal and limb deformities such as scoliosis.
- Technologies to promote bone healing and regeneration, such as BioCartilage and Pedigree matrix.
OrthoPediatrics Corp also has partnerships with other companies, such as Bioretec and PhyzioMedics, to develop innovative products and solutions that meet the needs of children and adolescents.
Conclusion:
OrthoPediatrics Corp is a leading provider of orthopedic solutions for children and adolescents. The company has a long history and an excellent reputation for developing innovative products and solutions tailored to the specific needs and requirements of this age group. The company works closely with specialists and hospitals to ensure that its products meet the highest medical standards and effectively help patients. OrthoPediatrics is one of the most popular companies on Eulerpool.
Frequently Asked Questions about OrthoPediatrics stock
EBIT per Employee of OrthoPediatrics is -353,106.38 USD in 2026.
EBIT per Employee of OrthoPediatrics changed from -418,170.21 USD to -353,106.38 USD, representing a -15.56% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Employee OrthoPediatrics since 2006 – with annual values, charts, and detailed analysis.
EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.
EBIT per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's OrthoPediatrics historically and in real time.
Access this data via the Eulerpool API
Workforce — OrthoPediatrics
All Key Metrics — OrthoPediatrics
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth